Boon Industries Inc.

Boon Engages DiOx+ Broad Spectrum Application while Finalizing $52M Contract

Jan 28, 2021


SACRAMENTO, CA, Jan. 28, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BOON Industries (OTC PINK:BNOW) (“BOON” or the “Company”), announces while the company is finalizing the distribution details for their contract worth $52M per year in revenue, it prepares to receive purchase orders for hospital based applications for an additional projected $12M annual revenue.

Justin Gonzalez, CEO, stated “Our proprietary DiOx+ product offers an activated Chlorine Dioxide (ClO2) broad spectrum disinfectant that kills harmful organisms within seconds with no residual toxicity. DiOx+ has applications in the food safety, healthcare, hospitality, transportation, and water treatment industries. Chlorine dioxide (ClO2) technology protects the environment and human health from dangerous bacteria and harmful by-products formed by other disinfection methods. For example, in the pulp and paper industry, the use of ClO2 has virtually eliminated dioxin in mill wastewater and has led to significant improvements in surrounding ecosystems. As a result, the Federal government is phasing out the use of chlorine in pulp mills over the next few years.

Mr. Gonzalez further stated “Our sales team is engaged with several hospital contracts and we anticipate immediate additional revenue streams of $12M per year. Boon will be part of the $6.5B healthcare disinfectant market. DiOx+ is a water-based formula and not an alcohol based product. Although the alcohol-based segment is likely to grow at the highest CAGR of over 12% during 2020–2026 as ethanol, IPA alcohols can be highly effective for killing microbes, viruses, and bacteria in the short term, this market is highly saturated. Our DiOx+ product is five hundred thousand times more oxidative than alcohol and more suitable to effectively manage the most resistant of germs. The liquid-based segment for our DiOx+ is projected to reach a revenue figure of close to $8 billion by 2026 as most commercial medical-grade disinfectants are in the liquid form. The U.S. disinfectant market is expected to reach over $5 billion by 2026 due to the prevalence of HAIs and the rise in acute and chronic diseases.”


Safe Harbor for Forward-Looking Statements: This news release contains forward-looking statements which are not statements of historical fact. Forward-looking statements include estimates and statements that describe the Company’s future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as “believes”, “anticipates”, “expects”, “estimates”, “may”, “could”, “would”, “will”, or “plan”. Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that actual results will meet management’s expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to changes in general economic and financial market conditions. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

Investor Relations
The Cervelle Group
Dave Donlin
Boon Industries, Inc.